Dr. Nagesh H. Jayaram, MD

Dr. Jayaram practices at Southeastern Medical Oncology Center in Jacksonville, North Carolina.

Dr. Jayaram's NPI, 1740466564, was assigned on January 10, 2008. Dr. Jayaram holds North Carolina license 2011-00902.

Dr. Jayaram's primary practice is Southeastern Medical Oncology Center, at 239 Station St, Jacksonville, NC 28546 in Onslow County. The practice phone is (919) 580-0000.

Dr. Jayaram's primary practice is Southeastern Medical Oncology Center in Jacksonville, North Carolina. Dr. Jayaram is also affiliated with Onslow Memorial Hospital. The medical group on file is Southeastern Medical Oncology Center (SMOC). Dmand AI also links Dr. Jayaram to 2 more hospitals, 1 group practice or clinic and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jayaram practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Jayaram's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Jayaram's licenses on file in 2 states: North Carolina and Indiana.

CMS data shows 195,695 Medicare services from Dr. Jayaram across 48 procedure codes in 2024, for 969 Medicare patients. Medicare paid $852,135 for them.

CMS counts 969 Medicare patients who saw Dr. Jayaram in 2024. The largest group is 65 to 74, with 421 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jayaram's median patient age at 66, with 68% women.

In 2024, Dr. Jayaram wrote 2,750 Medicare Part D claims for 363 patients. 74% of them were for generic drugs. CMS names the drug for 2,049 of them, across 63 drugs with 11 or more claims each, at $4,578,350 in total drug cost. In 2023, CMS named 1,823 claims across 68 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Jayaram for performance year 2024, reported as part of a group. Dr. Jayaram accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Jayaram, published from 2013 to 2016. Dr. Jayaram's most frequent co-authors are Ethan M. Basch, MD, Jean M. Connors, MD and Monic R. Drescher, MD.

Dmand AI links Dr. Jayaram to 10 clinical trials, 6 of them phase 3 studies. 6 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Melanoma and Nevi and Melanomas. National Cancer Institute (NCI) sponsors the most, 8.

CMS Open Payments shows 444 general payments to Dr. Jayaram from 71 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 42% of the total. Jazz Pharmaceuticals Inc. paid the most, $8,471. It also lists 1 research payment totaling $190 in 2018.